Literature DB >> 3003375

Type I topoisomerase activity after infection of enucleated, synchronized mouse L cells by vaccinia virus.

S K Poddar, W R Bauer.   

Abstract

The time course of appearance of type I topoisomerase activity after the infection of mouse L cytoplasts by vaccinia virus was determined. When the enucleation procedure was carried out with unsynchronized cell cultures, a high level of host-cell-specific type I topoisomerase activity was found associated with the resulting cytoplasts. If cells were first synchronized by the two-cycle thymidine block method and then enucleated after release, the level of host type I topoisomerase activity was also high for S-phase-enucleated cells but was very low for cytoplasts prepared from cells previously synchronized and enucleated during either the G1 or the G2 phase. After the infection of G1-phase-enucleated cytoplasts with vaccinia virus, newly synthesized type I topoisomerase activity first appeared at about 3 h postinfection. Virosomes were isolated from the infected, synchronized cytoplasts and assayed for the presence of type I topoisomerase activity. The activity remained at the top of a sucrose gradient, well resolved from the virosome fraction, at the low salt levels (0.01 M KCl, 0.01 M Tris hydrochloride, pH 8.0) normally used in the course of virosome purification. If the sedimentation was at the higher salt concentration (0.15 M KCl) at which the enzyme shows optimal activity, type I topoisomerase cosedimented with the virosome fraction onto the sucrose gradient cushion. These results show that the type I topoisomerase activity dependent upon vaccinia virus infection may be detected with high sensitivity in G1-phase-enucleated cytoplasts. The association with virosomes is consistent with an involvement of topoisomerase activity either in DNA replication or in late transcription.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003375      PMCID: PMC252754     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  A preparative method for obtaining enucleated mammalian cells.

Authors:  M H Wigler; I B Weinstein
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

2.  Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA.

Authors:  P Geshelin; K I Berns
Journal:  J Mol Biol       Date:  1974-10-05       Impact factor: 5.469

3.  Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis.

Authors:  P N Rao; R T Johnson
Journal:  Nature       Date:  1970-01-10       Impact factor: 49.962

4.  A convenient method for enucleating cells in quantity.

Authors:  E A Follett
Journal:  Exp Cell Res       Date:  1974-03-15       Impact factor: 3.905

5.  Characterization of a polyriboadenylate polymerase from vaccinia virions.

Authors:  B Moss; E N Rosenblum; A Gershowitz
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

6.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

7.  Vaccinia virus replication. I. Requirement for the host-cell nucleus.

Authors:  D E Hruby; L A Guarino; J R Kates
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Poly(A) polymerase from vaccinia virus-infected cells. I. Partial purification and characterization.

Authors:  C Brakel; J R Kates
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

9.  Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins.

Authors:  T H Pennington; E A Follett
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

10.  Variation in DNA swivel enzyme activity during the mammalian cell cycle.

Authors:  B H Rosenberg; G Ungers; J F Deutsch
Journal:  Nucleic Acids Res       Date:  1976-12       Impact factor: 16.971

View more
  5 in total

1.  Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.

Authors:  S Shuman; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase.

Authors:  M B Slabaugh; C K Mathews
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

3.  Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.

Authors:  M L Wong; M T Hsu
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Characterization of small nontranslated polyadenylylated RNAs in vaccinia virus-infected cells.

Authors:  C Lu; R Bablanian
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Role of luteal cell nucleus in the expression of gonadotropin action.

Authors:  P E Bibbins; C V Rao; F R Carman; N Chegini; Z M Lei
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.